# The Effect of 6% Hydroxyethyl Starch 130/0.4 on Blood Loss and Coagulation in Patients Medicated With Antiplatelet Agents Prior to Off-Pump Coronary Bypass Graft Surgery

> **NCT01051206** · PHASE4 · COMPLETED · sponsor: **Yonsei University** · enrollment: 106 (estimated)

## Conditions studied

- Coronary Artery Occlusive Disease

## Interventions

- **DRUG:** 6% hydroxyethyl Stach 130/0.4

## Key facts

- **NCT ID:** NCT01051206
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2010-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01051206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01051206, "The Effect of 6% Hydroxyethyl Starch 130/0.4 on Blood Loss and Coagulation in Patients Medicated With Antiplatelet Agents Prior to Off-Pump Coronary Bypass Graft Surgery". Retrieved via AI Analytics 2026-06-27 from https://api.ai-analytics.org/clinical/NCT01051206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*